https://www.businessline.global/celltrion-group-announces-positive-top-line-efficacy-and-safety-data-from-global-phase-ii-iii-clinical-trial-of-covid-19-treatment-candidate-ct-p59/press-release/
Celltrion Group announces positive top-line efficacy and safety data from global Phase II/III clinical trial of COVID-19 treatment candidate CT-P59